Back to search

Peptide record

TPDB24975

Antibacterial Anticancer Toxicity standard
19 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB24975
Antibacterial Anticancer Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides
Peptipedia
standard
No
A 19-aa standard natural multi-activity (Antibacterial, Anticancer, and Toxicity) peptide sequence curated from Peptipedia, with an available 3D structural model.
Sequence
RLFRRVKKVAGKIAKRIWK
Physicochemical Analysis
C110H193N37O20
NDCEQHMPSTY
K
2353.98
12.89
9
0
9
+9
3.84
-0.589
102.63
Mammalian: 1 hour Yeast: 2 min E.coli: 2 min
5500
233.65
0
Residue Composition
number
2
A
4
R
0
N
0
D
0
C
0
E
0
Q
1
G
0
H
2
I
1
L
5
K
0
M
1
F
0
P
0
S
0
T
1
W
0
Y
2
V
Amino Acid Distribution
A: 2 R: 4 N: 0 D: 0 C: 0 E: 0 Q: 0 G: 1 H: 0 I: 2 L: 1 K: 5 M: 0 F: 1 P: 0 S: 0 T: 0 W: 1 Y: 0 V: 2
Chemical Descriptors
19
C110H193N37O20
2353.98
12.89
+9
3.84
-0.589
Evidence Records 2 records
Evidence 1 Activity

Activity

10% Hemolysis
Toxicity
>250 µg/mL
Hemolytic Cytotoxic
10% Hemolysis | >250 | µg/mL | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Novel D-form of hybrid peptide (D-AP19) rapidly kills Acinetobacter baumannii while tolerating proteolytic enzymes. | Sci Rep | 2022
Evidence 2 Activity

Activity

7.25% Hemolysis
Toxicity
250 µg/mL
Hemolytic Cytotoxic
7.25% Hemolysis | 250 | µg/mL | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Novel D-form of hybrid peptide (D-AP19) rapidly kills Acinetobacter baumannii while tolerating proteolytic enzymes. | Sci Rep | 2022